The instruction for medical use
of Relif® medicine Ultra
the Trade name
of Relif® Ultra
the International unlicensed name
Is not present
the Dosage form
Suppositories rectal
the Structure
1 suppositories contains
active agents: sulfate zinc monohydrate of 11 mg, Hydrocortisoni acetas of 10 mg,
excipients: cocoa butter (teobromovy oil), calcium hydrophosphate anhydrous, magnesium stearate, methylparahydroxybenzoate, propilparagidroksibenzoat.
The description
Evenly opaque, from pale yellow till light yellow color suppositories, a torpedo-shaped form, with a fish smell.
Pharmacotherapeutic group
of Means for treatment of hemorrhoids and anal cracks for topical administration. Other means for treatment of hemorrhoids and anal cracks for topical administration.
The ATX C05AX code
the Pharmacological
Hydrocortisoni acetas properties oppresses discharge of mediators of inflammation, slows down metabolism of arachidonic acid. At topical administration possesses the anti-inflammatory, antiallergic, vasoconstrictive, desensibilizing, antiedematous and antipruritic action.
Zinc sulfate promotes healing of wounds and erosion.
The drug Relif Ultra has the calming effect in the itching, burning, discomfort connected with hemorrhoids.
Indications
– external and internal hemorrhoids
– a crack, fistula, an ulcer, an erosion of perianal area and a rectum
– other diseases which are followed by the significant inflammatory manifestations in anorectal area
– a proctitis
– an anal itching, eczema, dermatitis of the perianal
Route of administration area and a dose
to use Drug after holding hygienic procedures. To enter into a rectum on one suppository up to 4 times a day (in the morning, in the evening and after each bowel emptying).
Side effect
local allergic reactions (hyperaemia, puffiness, an itching) Are possible.
Contraindications
– the increased individual sensitivity to any of drug components
– specific (bacterial, fungal, virus, tubercular) defeats of anorectal area
– a new growth in an anus
– children's age up to 12 years
Medicinal interactions
Data on influence of candles of Relif® Ultra on a pharmacodynamics and pharmacokinetics of other medicines at topical administration are absent.
The special
instructions Pregnancy and a lactation
during pregnancy and a lactation the use of drug is possible only after careful assessment of a ratio advantage / risk both for mother, and for a fruit or the child.
The feature of influence on ability to run transport or potentially dangerous mechanisms
does not influence.
Overdose
Data on overdose of drug are absent. The overdose is a little probable, drug is shown for topical administration and systemic action
the Form of release and packing
On 6 suppositories in blister strip packaging from a film has no polyvinylchloride / polyethylene.
On 2 planimetric packs together with the instruction for medical use in the state and Russian languages place in a pack from cardboard.
To Store storage conditions at a temperature not above 25 °C.
To store out of children's reach!
Period of storage
2 years.
Not to use after the expiration date specified on packing.
Prescription status
Without prescription.
Producer Istitouto De Angeli of Neuter of l.,
50066 Reggello (Florence), Locke. Prulli 103/c, Italy
the Name and the country of the owner of the registration certificate
of Bayer Konsyyumer Ker AG, Switzerland
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of a product (goods):
TOO Bayer KAZ Timiryazev St., 42, business center Expo-City, peahens. 15
050057 Almaty, Republic of Kazakhstan
Ph.: +7 727 258 80 40
Fax: +7 727 244 70 01
e-mail: kz.claims@bayer.com
of Relif® medicine Ultra
the Trade name
of Relif® Ultra
the International unlicensed name
Is not present
the Dosage form
Suppositories rectal
the Structure
1 suppositories contains
active agents: sulfate zinc monohydrate of 11 mg, Hydrocortisoni acetas of 10 mg,
excipients: cocoa butter (teobromovy oil), calcium hydrophosphate anhydrous, magnesium stearate, methylparahydroxybenzoate, propilparagidroksibenzoat.
The description
Evenly opaque, from pale yellow till light yellow color suppositories, a torpedo-shaped form, with a fish smell.
Pharmacotherapeutic group
of Means for treatment of hemorrhoids and anal cracks for topical administration. Other means for treatment of hemorrhoids and anal cracks for topical administration.
The ATX C05AX code
the Pharmacological
Hydrocortisoni acetas properties oppresses discharge of mediators of inflammation, slows down metabolism of arachidonic acid. At topical administration possesses the anti-inflammatory, antiallergic, vasoconstrictive, desensibilizing, antiedematous and antipruritic action.
Zinc sulfate promotes healing of wounds and erosion.
The drug Relif Ultra has the calming effect in the itching, burning, discomfort connected with hemorrhoids.
Indications
– external and internal hemorrhoids
– a crack, fistula, an ulcer, an erosion of perianal area and a rectum
– other diseases which are followed by the significant inflammatory manifestations in anorectal area
– a proctitis
– an anal itching, eczema, dermatitis of the perianal
Route of administration area and a dose
to use Drug after holding hygienic procedures. To enter into a rectum on one suppository up to 4 times a day (in the morning, in the evening and after each bowel emptying).
Side effect
local allergic reactions (hyperaemia, puffiness, an itching) Are possible.
Contraindications
– the increased individual sensitivity to any of drug components
– specific (bacterial, fungal, virus, tubercular) defeats of anorectal area
– a new growth in an anus
– children's age up to 12 years
Medicinal interactions
Data on influence of candles of Relif® Ultra on a pharmacodynamics and pharmacokinetics of other medicines at topical administration are absent.
The special
instructions Pregnancy and a lactation
during pregnancy and a lactation the use of drug is possible only after careful assessment of a ratio advantage / risk both for mother, and for a fruit or the child.
The feature of influence on ability to run transport or potentially dangerous mechanisms
does not influence.
Overdose
Data on overdose of drug are absent. The overdose is a little probable, drug is shown for topical administration and systemic action
the Form of release and packing
On 6 suppositories in blister strip packaging from a film has no polyvinylchloride / polyethylene.
On 2 planimetric packs together with the instruction for medical use in the state and Russian languages place in a pack from cardboard.
To Store storage conditions at a temperature not above 25 °C.
To store out of children's reach!
Period of storage
2 years.
Not to use after the expiration date specified on packing.
Prescription status
Without prescription.
Producer Istitouto De Angeli of Neuter of l.,
50066 Reggello (Florence), Locke. Prulli 103/c, Italy
the Name and the country of the owner of the registration certificate
of Bayer Konsyyumer Ker AG, Switzerland
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of a product (goods):
TOO Bayer KAZ Timiryazev St., 42, business center Expo-City, peahens. 15
050057 Almaty, Republic of Kazakhstan
Ph.: +7 727 258 80 40
Fax: +7 727 244 70 01
e-mail: kz.claims@bayer.com
Related Products
Pharmatis to Astellas Pharma Europe BV, The Netherlands (France)
Phosphalugel® 16 g x 20 sachets
$39.00
